再鼎医药(09688.HK)拟11月6日举行董事会会议审批第三季度业绩

Core Viewpoint - The company, Zai Lab (09688.HK), announced that its board's audit committee will review and approve the unaudited quarterly performance for the third quarter ending September 30, 2025, on November 6, 2025, in accordance with US GAAP and SEC regulations [1] Group 1 - The board's audit committee is scheduled to meet on November 6, 2025 [1] - The meeting will focus on the unaudited quarterly results for the three and nine months ending September 30, 2025 [1] - The results will be prepared in compliance with US GAAP and applicable SEC rules [1]